1 |
MadjidM, Safavi-NaeiniP, SolomonSD,et al.Potential effects of coronaviruses on the cardiovascular system: a review[J].JAMA Cardiol,2020,5 (7):831-840.
|
2 |
ChenC, ZhouY, WangDW.SARS-CoV-2: a potential novel etiology of fulminant myocarditis[J].Herz,2020,45 (3):230-232.
|
3 |
王朗, 何文博, 余小梅, 等. 心肌损伤对新型冠状病毒肺炎患者临床预后的影响[J]. 中华心血管病杂志, 2020, 48 (6) : 461-466.
|
4 |
国家卫生健康委疾病预防控制局. 新冠病毒疫苗接种技术指南(第一版) [J]. 中国卫生经济, 2021, 40 (4) : 封2,前插1.
|
5 |
岳勇, 梁娴, 毛毅, 等. 新型冠状病毒疫苗接种对成都市境外输入病例流行病学及临床特征的影响分析[J]. 中华流行病学杂志, 2021, 42 (8) : 1365-1370.
|
6 |
KirolaL.Genetic emergence of B.1.617.2 in COVID-19[J].New Microbes New Infect,2021 (43):100929.
|
7 |
LiuY, YangB, LiuL,et al.Occupational character-istics in the outbreak of the COVID-19 Delta variant in Nanjing, China: rethinking the occupational health and safety vulnerability of essential workers[J].Int J Environ Res Public Health,2021,18 (20):10734.
|
8 |
国家老年医学中心/国家老年疾病临床医学研究中心, 中国老年医学学会心血管病分会, 北京医学会心血管病学会影像学组. 新型冠状病毒肺炎相关心肌损伤的临床管理专家建议(第一版) [J]. 中国循环杂志, 2020, 35 (4) : 326-330.
|
9 |
HuangC, WangY, LiX,et al.Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China[J].Lancet,2020,395 (10223):497-506.
|
10 |
吴高义, 林素涵, 陈玉熹, 等. 新型冠状病毒肺炎患者104例的流行病学和临床特征分析[J/CD]. 中华危重症医学杂志(电子版) , 2020, 13 (2) : 124-127.
|
11 |
LalaA, JohnsonKW, JanuzziJL,et al.Prevalence and impact of myocardial injury in patients hospitalized with COVID-19 infection[J].J Am Coll Cardiol,2020,76 (5):533-546.
|
12 |
XuH, HouK, XuR,et al.Clinical characteristics and risk factors of cardiac involvement in COVID-19[J].J Am Heart Assoc,2020,9 (18):e016807.
|
13 |
NascimentoJHP, CostaRLD, SimvoulidisLFN,et al.COVID-19 and myocardial injury in a Brazilian ICU: high incidence and higher risk of in-hospital mortality[J].Arq Bras Cardiol,2021,116 (2):275-282.
|
14 |
AdeghateEA, EidN, SinghJ.Mechanisms of COVID-19-induced heart failure: a short review[R].Heart Fail Rev,2021,26 (2):363-369.
|
15 |
Babapoor-FarrokhranS, GillD, WalkerJ,et al.Myocardial injury and COVID-19: possible mechanisms[R].Life Sci,2020 (253):117723.
|
16 |
ChengX, CaiG, WenX,et al.Clinical characteristics and fatal outcomes of hypertension in patients with severe COVID-19[J].Aging (Albany NY),2020,12 (23):23436-23449.
|
17 |
OuditGY, KassiriZ, JiangC,et al.SARS-coronavirus modulation of myocardial ACE2 expression and inflammation in patients with SARS[J].Eur J Clin Invest,2009,39 (7):618-625.
|
18 |
BertoliniA, van de PeppelIP, BodewesFAJA,et al.Abnormal liver function tests in patients with COVID-19: relevance and potential pathogenesis[J].Hepatology,2020,72 (5):1864-1872.
|
19 |
JothimaniD, VenugopalR, AbedinMF,et al.COVID-19 and the liver[J].J Hepatol,2020,73 (5):1231-1240.
|
20 |
LeeCCE, AliK, ConnellD,et al.COVID-19-associated cardiovascular complications[J].Diseases,2021,9 (3):47.
|
21 |
GuzikTJ, MohiddinSA, DimarcoA,et al.COVID-19 and the cardiovascular system: implications for risk assessment, diagnosis, and treatment options[J].Cardiovasc Res,2020,116 (10):1666-1687.
|
22 |
HendrenNS, DraznerMH, BozkurtB,et al.Description and proposed management of the acute COVID-19 cardiovascular syndrome[J].Circulation,2020,141 (23):1903-1914.
|